Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1151 of 1,261
  1. US 6759208

    High throughput screening assays using fatty acid synthetic enzymes

    Xenon Genetics Inc. Β· Granted Jul 6, 2004 Β· Expires Jul 1, 2024

    expired
  2. US 6759385

    Methods to treat undesirable immune responses

    Regents of the University of Minnesota Β· Granted Jul 6, 2004 Β· Expires Jul 1, 2024

    expired
  3. US 6759538

    Substituted diphenyl heterocycles useful for treating HCV infection

    Rigel Pharmaceuticals, Inc. Β· Granted Jul 6, 2004 Β· Expires Jul 1, 2024

    expired
  4. US 6758828

    Catheter for cell delivery in tissue

    Regents of the University of Minnesota Β· Granted Jul 6, 2004 Β· Expires Jul 1, 2024

    expired
  5. US 6759044

    Cryptopain antibodies for prophylaxis, treatment, diagnosis and detection of Cryptosporidium species

    The Regents of the University of California Β· Granted Jul 6, 2004 Β· Expires Jul 1, 2024

    expired
  6. US 6759535

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated Β· Granted Jul 6, 2004 Β· Expires Jul 1, 2024

    expired
  7. US 6756036

    Methods for treating cancer using PSCA antibodies and fragments thereof

    The Regents of the University of California Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  8. US 6756393

    Azacyclic compounds

    ACADIA Pharmaceuticals Inc. Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  9. US 6756229

    Human cell line showing stable expression of cytochromes P450

    Takeda Chemical Industries Ltd. Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  10. US 6756210

    Linoleic acid diol and glucuronide conjugate levels as diagnostic markers of disorders of abnormal regulation of cytochrome P450 metabolism of unsaturated fatty acids

    The Regents of the University of California Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  11. US 6756201

    Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1

    The United States of America as represented by the Department of Health and Services Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  12. US 6756062

    Preparation of drug particles using evaporation precipitation into aqueous solutions

    The Board of Regents of the University of Texas System Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  13. US 6756038

    Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  14. US 6756055

    Cationic lipid compositions targeting angiogenic endothelial cells

    The Regents of the University of California Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  15. US 6756033

    Method for delivering benzindene prostaglandins by inhalation

    United Therapeutics Corporation Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  16. US 6756399

    Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  17. US 6756408

    Methods and materials for protecting against myocardial cell damage related to coronary intervention by regional beta blocker therapy

    The Board of Regents of the University of Texas System Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  18. US 6756400

    Sodium channel modulators

    Theravance, Inc. Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  19. US 6756472

    Process for producing polymer

    Takeda Chemical Industries Ltd. Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  20. US 6756518

    Scar reduction

    United States Surgical Corporation Β· Granted Jun 29, 2004 Β· Expires Jun 24, 2024

    expired
  21. US 6752995

    Nucleic acid and polypeptide sequences useful as adjuvants

    The Board of Regents of the University of Texas System Β· Granted Jun 22, 2004 Β· Expires Jun 17, 2024

    expired
  22. US 6753417

    UspA1 and UspA2 antigens of Moraxella catarrhalis

    The Board of Regents of the University of Texas System Β· Granted Jun 22, 2004 Β· Expires Jun 17, 2024

    expired
  23. US 6753317

    Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 22, 2004 Β· Expires Jun 17, 2024

    expired
  24. US 6752987

    Adenovirus encoding human adenylylcyclase (AC) VI

    The Regents of the University of California Β· Granted Jun 22, 2004 Β· Expires Jun 17, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.